Registered company number 03807203
Registered charity number 1077638
THE UNIVERSITY COLLEGE
LONDON HOSPITALS
CHARITABLE FOUNDATION
(A company limited by guarantee)
Annual Report and Financial Statements
31 March 2025

THE UNIVERSITY COLLEGE LONDON HOSPITALS
CHARITABLE FOUNDATION
Annual Report and Financial statements for the year ended 31 March
2025
Contents
Legal and administrative information
Trustees report
Independent Examiner's Report
Statement of financial activities
Statement of financial activities (31 March 2024)
Balance sheet
Notes to the financial statements
Pages
1
2-6
7
8
9
10
11 - 21

THE UNIVERSITY COLLEGE LONDON HOSPITALS
CHARITABLE FOUNDATION
Legal and administrative information
Chairman & Treasurer
Dr Christopher Moran
Deputy Chairman
Mr Colin Reilly
Charlty Registration Number
1077638
Company Number
0380720:
Principal address and registered office
Floor 1b Maple House
149 Tottenham Court Road
London
WIT 7NF
Independent Examiner
Heather Wheelhouse ACA
BDO LLP
55 Baker Street
London
WIU 7EU
Solicitors
Linklaters
One Silk Street
London
ECZY 8HQ

THE UNIVERSITY COLLEGE LONDON HOSPITALS
CHARITABLE FOUNDATION
Trustees report (incorporating the report of the Directors) for the year
ended 31 March 2025
The Trustees, who are the directors of the company, present their report and financial statements for The
plicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicab
the UK and Republic of Ireland (FRS 102) (effective 1 January 201!
Status and objects
The Foundation was incorporated on 14 July 1999 and is a company limited by guarantee which is incorporated
The Foundation was established to promote the relief and prevention of sickness and disease and to advance
medical education. Funds raised by the Foundation can be used for the erection and maintenance of buildings,
the purchase and maintenance of medical equipment, for education, for employment of staff and for clinical
research.
Public Benefit
We have referred to the guidance contained in the Charity Commission's general guidance on public benefit
when reviewing our aims and objectives and in planning our future activities.
Governance
The Trustees are responsible for the overall management and decision making for the Foundation. A list of the
Trustees who served during the year is set out on page 4 in this report. In order to promote good governance
and effectiveness, new Trustees are offered an induction programme at the time of their proposed appointment.
This is designed to ensure that new Trustees are briefed on the Foundation in order to understand its
purpose and its legal and financial position. The programme also covers the duties and responsibilities of
trustees.
The Trustees determine the direction and policy of the Foundation in response to requests from University
College London Hospitals NHS Foundation Trust ("UCLH Trust").
The Trustees meet three to four times a year and the Chairman oversees the administration and management
of the charity.
Investment powers
Under the Memorandum and Articles of Association, the charity has the power to make any investment which
the Trustees see fit.
2

THE UNIVERSITY COLLEGE LONDON HOSPITALS
CHARITABLE FOUNDATION
Trustees report (incorporating the report of the Directors) for the year
ended 31 March 2025 (continued)
Review of the year and future plans
During the year UCLH Charitable Foundation continued its primary focus of supporting various projects acros
ne hospitals within the UCLH NHS Foundation Trust. Some of these projects are:
Stroke Services Unit at UCLH
In June 2024, we received E50,000 from The Woosnam Foundation and another £50,000 from The Lord Leonard
and Lady Estelle Wolfson Foundation. These generous contributions were made to The Michael Feldman and
The Lady Estelle Wolfson Bursary Fund to support Stroke Services at UCLH.
This is an ongoing grant (we have received annual funds from The Woosnam Foundation since 2019).
The Michael Feldman and The Lady Estelle Wolfson Bursary Fund supports the purchase of equipment for the
Stroke Unit as well as the education, training and development of staff who work within Stroke Services at UCLH
under Dr David Turner, Stroke and Geriatric Consultant for UCLH.
The UCLH Lung and Heart Bioresource
UCLH Charitable Foundation continues fundraising to support this pioneering research project that is improving
early detection rates and survival rates for lung cancer, chronic obstructive pulmonary disease (COPD) and
cardiovascular disease (CVD). The UCLH Lung and Heart Bioresource is a vast and unique dataset of biological
information gathered by the innovative SUMMIT Study, one of the largest interventional trials of its kind. This
large and comprehensive study into these three fatal diseases allows scientists a unique means of studying
individuals at the highest risk of developing these particular diseases. The biological findings gathered by the
study are paving the way for routine early screening for Lung Cancer, COPD and CVD.
We currently have an agreement with the UCH NHS Foundation Trust to support the salary costs of a Clinical
Fellow working on the Lung and Heart Bioresource for three years (from 2024). The commitment was made in
February 2023. The commitment was communicated fully during the Independent Examination process in
2022/23. No candidate was hired at the time and no liability was recorded in the 2022/23 financial year.
At the commencement of the 2024/25 financial year, the Clinical Fellow position was filled, and the charity has
commenced funding for the position. The nature of the original commitment has been reevaluated in line with the
treatment of the SORP, and it is deemed that the Charity's commitment in 2022/23 should lead to a full
recognition in that period as opposed to 2024/25. This has been reflected within the Lung & Heart Bioresource
restricted fund (See Note 14).
Sarcoma Fund
We are currently part funding a one year post for a Clinical Research Fellow working on the Sarcoma Unit at
University College Hospital.
The project that the Clinical Research Fellow is working on will involve developing a clinical trial in definitive
UCH Macmillan Cancer Centre
The UCH Macmillan Cancer Centre has been a fundraising project for UCL Hospitals Charitable Foundation for
Additional funds
UCL Hospitals Charitable Foundation also holds funds which support various departments and areas of research
throughout the UCLH campus such as: Obstetrics; Sarcoid/CFA and Lung Cancer.
3

THE UNIVERSITY COLLEGE LONDON HOSPITALS
CHARITABLE FOUNDATION
Trustees report (incorporating the report of the Directors) for the year
ended 31 March 2025 (continued)
Financial Review
During the year ended 31 March 2025 the Foundation's donation and legacy income was £142,088 (2024:
£115,847). At the year end the charity is reporting net expenditure of £65K (2024: £66K). However, the balance
sheet remains strong with net assets of £242K and cash available of £481K. Details of the movements on all
restricted funds are given in note 12 on page 17. Unrestricted expenditure costs of £100.4k relate to one full
time employee together with associated administration and rent costs. Against this amount, unrestricted
donations in a challenging environment for funds were received totaling £38.0k, which were predominately
received in small donations (less than £1.5K) together with a donation from Trustee of £7.7k to clear the
unrestricted deficit brought forward.
Going Concern & Plans for the future
We plan to continue our fundraising efforts and objectives for our various funds over the next year by continuing
to make approaches for support to individual donors, companies, foundations and trusts. We have legacies
planned to continue in 2025/26. Confirmation of support has been provided from Chesterlodge Limited, of which
Dr Christopher Moran (Chairman/Trustee) is the sole shareholder and PSC. The assessment of the going
concern is detailed within note 2(b).
Reserves policy
Trustees believe that the Foundation should have adequate reserves to allow flexibility to support projects across
the eight hospitals within the UCLH Trust. The free' reserves at 31 March 2025 were a deficit of E(70,017) (2024:
(£7,683)). Chesterlodge Limited (a controlled by a Trustee of the charity) has provided a letter of support. This
letter ensures sufficient funding for more than 12 months from the date of signing these financial statements. It
covers the deficit in unrestricted funds and all unrestricted costs over the same period.
Risk exposure
The Trustees have addressed the major risks to which the Charity is exposed, in particular those relating to its
operations and finances, and are satisfied that the systems in place are sufficient to minimise any exposure
identified.
UCH Charitable Foundation holds reserves and these will be used, together with support from Trustees,
accordingly to ensure the charity remains a going concern.
Trustees
The Trustees of the Foundation who served during the year were:
Dr Christopher Moran (Chairman)
Dr Margaret Spittle OBE, FRCP, FRCR
Dr Jeremy George MA, MSc, MD, FRCP
Mr Colin Reilly
4

THE UNIVERSITY COLLEGE LONDON HOSPITALS
CHARITABLE FOUNDATION
Trustees report (incorporating the report of the Directors) for the year
ended 31 March 2025 (continued)
Statement of Trustees responsibilities
The Trustees (who are also Directors of the Foundation for the purposes of company law) are responsible for
preparing the Report of the Trustees and the financial statements in accordance with applicable law and United
Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
Company law requires the Directors to prepare financial statements for each financial year. Under that law the
Directors have elected to prepare the financial statements in accordance with United Kingdom Generally
Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company lav
the Directors must not approve the financial statements unless they are satisfied that they give a true and fair
view of the state of affairs of the company and of the income and expenditure of the charitable company for that
select suitable accounting policies and apply them consistently;
observe the methods and principles in the Charities SORP;
make judgements and estimates that are reasonable and prudent;
- state whether applicable UK Accounting Standards have been followed, subject to any material departures
disclosed and explained in the financial statements;
- prepare the financial statements on the going concer basis unless it is inappropriate to presume that the
charitable company will continue in business.
for the prevention and detection of fraud and other irregularities.
The Trustees are responsible for the maintenance and integrity of the corporate and financial information
included on the charity's website. Legislation in the United Kingdom governing the preparation and dissemination
of the financial statements and other information included in annual reports may differ from legislation in other
jurisdictions.
In so far as the Trustees are aware:
• there is no relevant information of which the charitable company's independent examiner is unaware; and
• the Trustees have taken all steps that they ought to have taken to make themselves aware of any relevant
information and to establish that the independent examiner is aware of that information.
5

THE UNIVERSITY COLLEGE LONDON HOSPITALS
CHARITABLE FOUNDATION
Trustees report (incorporating the report of the Directors) for the year
ended 31 March 2025 (continued)
Small company provisions
This report has been prepared in accordance with the special provisions for small companies under Part 15 of
the Companies Act 2006.
Dr Christopher Morar
Chairman
Date: 16/12/2025
6

Independent Examiner's Report to the members and Trustees of The
University College London Hospitals Charitable Foundation
I report to the charity's Trustees on the accounts of the company for the year ended 31 March 2025 which are
set out on pages 8 to 21.
This report is made solely to the charity's trustees, as a body, in accordance with Regulation 31 of the
Charities (Accounts and Reports) Regulations 2008. My work has been undertaken so that I might state to the
Responsibilities and basis for report
As the charity's trustees of the Company (and also its directors for the purposes of company law) you are
responsible for the preparation of the accounts in accordance with the requirements of the Companies Act
2006 ('the 2006 Act').
Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the
2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's
accounts as carried out under section 145 of the Charities Act 2011 ('the 2011 Act). In carrying out my
examination I have followed the Directions given by the Charity Commission under section 145(5) (b) of the
2011 Act.
Independent examiner's statement
I have completed my examination. I confirm that no matters have come to my attention in connection with the
examination giving me cause to believe:
1 accounting records were not kept in respect of the Company as required by section 386 of the 2006 Act; or
2. the accounts do not accord with those records; or
3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any
requirement that the accounts give a 'true and fair view which is not a matter considered as part of an
independent examination; or
4.the accounts have not been prepared in accordance with the methods and principles of the Statement of
Recommended Practice for accounting and reporting by charities (applicable to charities preparing their
accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland
(FRS 102)).
I have no concerns and have come across no other matters in connection with the examination to which
attention should be drawn in this report in order to enable a proper understanding of the accounts to be
reached.
Signed:
Heather Wheelhouse ACA
BDO LLP
London, UK
Date
BDO LLP is a limited liability partnership registered in England and Wales (with registered number OC305127)
7

THE UNIVERSITY COLLEGE LONDON
HOSPITALS CHARITABLE FOUNDATION
Statement of financial activities for the year ended 31 March 2025
(incorporating an income and expenditure account)
Note
Unrestricted
funds
€
Restricted
funds
€
Total funds
2025
€
Total funds
2024
(restated)
Income and expenditure
Income
Donations and legacies
Investment income
Total income
Expenditure
Cost of raising funds
Charitable activities
Total expenditure
Net expenditure
Fund balances
Balances brought forward
(restated - see Note 14)
Balances carried forward
6
38,072
-
38,072
3,600
96,806
100,406
(62,334)
104,016
16,040
120,056
123,178
123,178
(3,122)
142,088
16,040
158,128
3,600
219,984
223,584
(65,456)
115,847
16,803
132,650
32,892
165,435
198,327
(65,677)
(7,683)
(70,017)
315,015
311,893
307,332
241,876
373,009
307,332
I above amounts are derived from continuing operation
I gains and losses for the year are shown abov
The notes on pages 11 to 21 form part of these financial statements
8

THE UNIVERSITY COLLEGE LONDON
HOSPITALS CHARITABLE FOUNDATION
Statement of financial activities for the year ended 31 March 2024
(incorporating an income and expenditure account)
Note
Unrestricted
funds
€
Income and expenditure
Income
Donations and legacies
Investment income
Total income
Expenditure
Cost of raising funds
Charitable activities
Total expenditure
Net expenditure
Transfers between funds
Net movement in funds
Fund balances
Balances brought forward
(restated - see Note 14)
Balances carried forward
1 502
12,005
32,892
43,611
76,503
(64,498)
6,493
(58,005)
50,322
(7,683)
Restricted
funds
€
Total funds
2024
(restated)
104,345
16,300
115,847
16,803
120,645
132,650
121,824
32,892
165,435
121,824
198,327
(1,179)
(65,677)
(6,493)
(7,672)
-
(65,677)
322,687
373,009
315,015
307,332
Total funds
(restated)
177,706
8,080
185,786
85,938
630,190
716,128
(530,342)
-
(530,342)
903,351
373,009
All above amounts are derived from continuing operations.
All gains and losses for the year are shown above.
The notes on pages 11 to 21 form part of these financial statements
9

THE UNIVERSITY COLLEGE LONDON
HOSPITALS CHARITABLE FOUNDATION
Balance Sheet at 31 March 2025
Note
2025
€
2024
(restated)
Current assets
Debtors
Bank balances and cash in hand
9
899
480,849
1,448
570,225
Creditors: amounts falling due within one year
10
Net current assets
481,748
(154,708)
327,040
571,673
(107,666)
464,007
Creditors: amounts falling due greater than one year
10
(85,164)
(156,675)
Total assets less current liabilities
241,876
307,332
Unrestricted funds
Restricted funds
11
11
(70,017)
311,893
(7,681)
315,013
Total funds
241,876
307,332
The Trustees acknowledge their responsibilities for complying with the requirements of the Companies Act 200€
with respect to accounting records and the preparation of financial statements
For the financial year in question the company was entitled to exemption under section 477 of the Companies Act
2006 relating to small companies
No members have required the company to obtain an audit of its account for the year in question in accordance
with section 476 of the Companies Act 2006.
The directors acknowledge their responsibility for complying with the requirements of the Act with respect to
accounting records and for the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small
companies' regime.
The financial statements were approved by the Trustees and authorised for issue on
signed on their behalf by:
and were
or cheone mad
Chairman & Treasurer
Mr C Reilly
Deputy Chairman
The notes on pages 11 to 21 form part of these financial statements.
10

THE UNIVERSITY COLLEGE LONDON
HOSPITALS CHARITABLE FOUNDATION
Notes to the financial statements for the year ended 31 March 2025
1.
2.
Company information
The University College London Hospitals Charitable Foundation is a Charitable company limited by
guarantee incorporated and domiciled in England & Wales.
The Registered Office is Floor 1b Maple House, 149 Tottenham Court Road, London, W1T 7NF.
The principal activity of the Charity is to promote the relief and prevention of sickness and disease
and to advance medical education. The Company's registered number is 03807203. The registered
Charity number is 1077638.
The functional and presentational currency of these financial statements is GBP.
Accounting policies
a)
Accounting basis
The financial statements cover the period 1 April 2024 to 31 March 2025.
The financial statements have been prepared in accordance with Accounting and Reporting by
Charities: Statement of Recommended Practice applicable to charities preparing their accounts in
accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS
102) (effective 1 January 2019) - (Charities SORP (FRS 102)), the Financial Reporting standards
applicable in the UK and Republic of Ireland (FRS 102) the Companies Act 2006 and the Charities
Act 2011.
The charity meets the definition of a public benefit entity under FRS 102. Assets and liabilities are
initially recognised at historical cost or transaction value unless otherwise stated in the relevant policy
note(s).
They are prepared under the historical cost convention.
b)
Going concern
As of 31 March 2025, the charity had total reserves of £241,876 represented by (E70,017) of
unrestricted reserves and £311,893 restricted reserves. The majority of expenditure is within
restricted funds. The Foundation has received a letter of support from Chesterlodge Limited
(Company registration no 01611575) who will provide sufficient funding to ensure the charity will
have sufficient income generated over a period greater than 12 months from the date of these
financial statements to cover the deficit as of 31 March 2025 in unrestricted funds and all
unrestricted costs over the period to 31 December 2026.
On this basis, the Trustees have reviewed and made an assessment of the charity's ability ti
continue as a going concern for a period of at least twelve months from the date on which th
financial statements are approved. If in the worst case scenario no further external funds were
eceived by the charity, there would be sufficient support from Chesterlodge Limited to cover cost
or a period exceeding twelve months from the date of signing of these accounts. We plan t
continue our fundraising efforts and objectives for our various funds over the next year by continuing
This assessment indicates the ability of the entity to continue to operate as a going concern anc
therefore it is considered appropriate to prepare the accounts on a going concern basis
In making their assessment the Trustees do not consider there to be any material uncertainty
relating to events or conditions that individually or collectively may cast significant doubt on the
charity's ability to continue as a going concern.
11

THE UNIVERSITY COLLEGE LONDON
HOSPITALS CHARITABLE FOUNDATION
Notes to the financial statements for the year ended 31 March 2025 (continued)
2.
Accounting policies (continued)
c)
Al tomo i anded in the sam be ofFind lAces 0 ) wain the charly is legally entited
Legacies
egacies are included when the charity is advised by the personal representative of an estate tha
ayment will be made, or that the receipt is probable and the amount involved can be quantifier
e)
f)
g)
h)
i)
All expenditure is accounted for on an accruals basis, inclusive of irrecoverable VAT, and is
allocated to the appropriate heading in the accounts.
Costs of raising funds include the costs incurred in generating voluntary income and the costs o
lirect publicity intended to raise the profile of the charity
Charitable expenditure comprises services supplied and activities undertaken which are identifiable
as wholly or mainly in support of the charity's objectives.
overnance costs are those costs associated with the governance arrangements of the charity, an
rese include audit, legal advice for trustees, costs associated with trustee meetings and the co
of the preparation of the statutory accounts.
upport costs are those costs which enable fund generating and charitable activities to b
ndertaken. Costs that relate to more than one activity have been apportioned, with reference t
staff time, on a reasonable and consistent basis.
Grants payable
Grants payable are accounted for in the financial statements as liabilities when the Foundation has
either a legal or constructive obligation to meet.
Fund accounting
The Foundation has three types of funds for which it is responsible and which require separate
disclosure. These are as follows:
Restricted funds
Donations or legacies received which are earmarked by the donor for specific purposes. Such
purposes are within the overall aims of the Foundation.
Designated funds
These are funds set aside by the Trustees out of the General Fund for a specific purpose. There
were no designated funds in the year.
General fund
Funds, which are expendable at the discretion of the Trustees in furtherance of the objects of the
Foundation.
Capital expenditure
No expenditure below €500 is capitalised as the size and nature of the items purchased are not
considered material.
Financial Instruments
The trust only has financial assets and financial liabilities of a kind that qualify as basic financial
instruments. Basic financial instruments are recognised at transaction value.
12

THE UNIVERSITY COLLEGE LONDON
HOSPITALS CHARITABLE FOUNDATION
Notes to the financial statements for the year ended 31 March 2025 (continued)
2.
Accounting policies (continued)
i)
Judgments in applying accounting policies and key sources of estimation
preparing the Financial Statements, management is required to make estimates and assumptior
hich affect reported income, expenses, assets, liabilities and disclosure of contingent assets at
liabilities. Use of available information and application of judgement are inherent in the formation of
stimates, together with expectations of future events that are believed to be reasonable under thi
ircumstances. Actual results in the future could differ from such estimates
There are not considered to be any key areas of judgement in these financial statements.
3.
Income from donations and legacies
General donations
Legacies
Donations from charitable trusts
Donations from events
2025
€
38,072
10,016
142,088
2024
€
12,160
103,100
587
115,847
4.
Restricted income is £104,016 (2024: E104,345).
Interest receivable and similar income
2025
16,040
2024
16,803
5.
Interest receivable
Restricted income is £16,040 (2024: £16,300).
Costs of raising funds
Direct costs of fund raising activities
Staff costs
General overheads
2026
:
3,600
3,600
2024
5,251
20,331
7,310
32,892
Restricted expenditure is Enil (2024: Enil).
13

THE UNIVERSITY COLLEGE LONDON
HOSPITALS CHARITABLE FOUNDATION
Notes to the financial statements for the year ended 31 March 2025 (continued)
6.
Charitable activities
Medical salaries and direct costs
Staff costs
General overheads
Governance costs (note 7)
2025
96,849
86,774
23,049
13,312
2024
€
76,608
57,549
7,308
23,970
219,984
165,435
Restricted expenditure is £123,178 (2024: £121,824).
7.
Governance costs
Staff costs
Independent examination
Other costs
2025
€
9,627
3,685
13,312
2024
12,335
5,022
6,613
23,970
8.
Staff costs
Staff:
Gross
Employers NI
Pension
Self-employed:
Gross
2025
68,676
7,742
10,356
2024
€
63,973
8,211
10,030
-
8,000
86,774
90,214
One staff member (2024: One) is employed by the University College London Hospitals NHS Trust and is
contracted to work for the Foundation. Staff costs are charged to the Foundation on the basis of the time spent
working for the Foundation. 1 member of staff was paid more than £60,000 (2024: 1).
re Trustees consider themselves as comprising the key management personnel of the Foundation, in char
directing and controlling the Foundation. No Trustee received remuneration for services during the ye
(2024: nil) and received no benefits in kind (2024: nil). No Trustee claimed any expenses during the year (2024:
nil). No Trustee received any beneficial interest in any contract with the Foundation.

THE UNIVERSITY COLLEGE LONDON
HOSPITALS CHARITABLE FOUNDATION
Notes to the financial statements for the year ended 31 March 2025 (continued)
9.
Debtors
2025
€
2024
€
Due within one year
Interest receivable
899
1,448
899
1,448
10.
Creditors
Due within one year
Grant commitments
Other creditors and accruals
2025
€
122,151
32,557
154,708
78,856
28,810
107,666
Due greater than one year
Grant commitments
2025
€
85,164
2024
(restated)
156,675
85,164
156,675
The Foundation has entered into the following commitments
A commitment has been made by the Foundation to provide support for a Clinical Research Fellow in the Dr
Seddon's Sarcoma Fund (Note 12) totaling £43,640. This amount is due within one year, and included within
Grant commitments < one year (2024: ENil)
In February 2023 a commitment was made by the Foundation to provide support to fund a three year Lung &
Heart Bioresource Clinical Fellow in the Lung & Heart Bioresource Fund (Note 12) totaling £235,531. The full
commitment has been recognised as prior period adjustment (Note 14). At March 2025 £78,511 is included ir
Grant commitments < one year (2024 restated: £78,856), and £85,164 included in Grant commitments > one year
(2024 restated: £156,675).
15

THE UNIVERSITY COLLEGE LONDON
HOSPITALS CHARITABLE FOUNDATION
Notes to the financial statements for the year ended 31 March 2025 (continued)
11.
Analysis of net assets between funds
Bank
Debtors (note 9)
Creditors < 1 year (note 10)
Creditors > 1 year (note 10)
Unrestricted
(55,424)
114,593)
-
(70,017)
Restricted
Total 202€
536,273
899
(140,115)
(85,164)
480,849
899
(154,708)
(85,164)
311,893
241,876
The trustees are aware of the deficit in unrestricted funds, with confirmed legacies due to clear the deficit post
year end.
Analysis of net assets between funds (prior year restated)
Bank
Debtors (note 9)
Creditors < 1 year (note 10)
Creditors > 1 year (note 10)
Unrestricted Restricted Total 2024
16,520
124201)
(7,683)
553,705
1,448
(83,465)
(156,675)
315,015
570,225
1,448
(107,666)
(156,675)
307,332
16

THE UNIVERSITY COLLEGE LONDON
HOSPITALS CHARITABLE FOUNDATION
Notes to the financial statements for the year ended 31 March 2025 (continued)
12.
Restricted funds
2025
Transfer
Aids
Arthritis (Dr Fisher's RLHH
Research)
Cancer Clinical Trials
Cancer Day Centre
Cardiology Clinical Trials
Colorectal Cancer Unit
COX2 Sarcoid Project
Dr Seddon's Sarcoma Fund
Early Lung Cancer Project
Learning Disability Services
Lifebox
Lung & Heart Bioresource
Lungs For Living
The Michael Feldman & Lady Estelle
Wolfson Bursary Fund
Mitochondrial Fund
Multi-sensory Room
Paediatric Oncology Research Nurse
Paediatric Ward T11
Pranav Pandya's Obstetrics Fund
Radiopharmacy Facility
RLHH
RLHH Research
RNTNE Play Services Fund
Roald Dahl Fund
Rokitansky Syndrome Fund
Royal Nat. Throat Ear & Nose
Hospital
Sarcoid
Severe Asthma Unit
Stephen Green Fund
Stroke Unit
Therapy Services
Transplant Unit
UCLH Paediatric Epilepsy Uni
Young People's Unit
1
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
(Restated)
Balance
1 April
2024
-
5,873
1,708
3,031
3,456
141,906
265
4,827
66,829
28,241
18,344
436
2,206
16,122
185
295
321
1,471
Income
Expenditure
-
160
:
432
4,332
100
7,793
1,604
103,208
481
481
47,640
7,000
68,538
•..
:
:
12,693
3,545
315,015
240
744
321
160
120,056
-
-
-
-
-
123,178
-
Balance
31 March
2025
-
6,033
3,456
98,598
365
5,620
68,433
62,911
18,825
436
2,206
16,603
185
295
321
1,711
1,734
2,271
:
13,014
3,705
311,893

THE UNIVERSITY COLLEGE LONDON
HOSPITALS CHARITABLE FOUNDATION
Notes to the financial statements for the year ended 31 March 2025 (continued)
12.
Restricted funds (Prior year)
2024
Aids
Arthritis (Dr Fisher's RHH
Research)
Cancer Clinical Trials
Cancer Day Centre
Cardiology Clinical Trials
Colorectal Cancer Unit
COX2 Sarcoid Project
Dr Seddon's Sarcoma Fund
Early Lung Cancer Project
Learning Disability Services
Lifebox
Lung & Heart Bioresource
Lungs For Living
The Michael Feldman & Lady Estelle
Wolfson Bursary Fund
Mitochondrial Fund
Multi-sensory Room
Paediatric Oncology Research Nurse
Paediatric Ward T11
Pranav Pandya's Obstetrics Fund
Radiopharmacy Facility
RLHH R
RLHH Research
RNNE Play Services Fund
Roald Dahl Fund
Rokitansky Syndrome Fund
Royal Nat. Throat Ear & Nose
Hospital
Sarcoid
Severe Asthma Unit
Stephen Green Fund
Stroke Unit
Therapy Services
Transplant Unit
Young Peoples Upilepsy Unit
1
6
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
(Restated)
Balance
1 April
2023
€
600
5,701
911
1,065
3,139
3,355
1,137
146,985
174
77
46
1,332
80,114
Income
Expenditure
€
€
Transfer
€
(Restated)
Balance
31 March
2024
-
-
13
9
-
-
:
-
-
-
1,000
-
367
908
130
25
-
4,827
66,829
-
200
930
13,147
3,783
930
:
322,687
120,645
121,824
6,493
During the prior year, transfers were made from inactive restricted funds to unrestricted funds. This transfer was
nade due to certain restricted funds were unutilised for a significant period. This reallocation ensures that thes
unds can be effectively used to support our ongoing activities and was done in accordance with the charit
commission guidance.
12,693
3,545
315,015
18

THE UNIVERSITY COLLEGE LONDON
HOSPITALS CHARITABLE FOUNDATION
Notes to the financial statements for the year ended 31 March 2025 (continued)
12.
Restricted funds (continued)
Notes
(1.)
(2)
(3.)
(4.)
(5.)
(6.)
These funds were for research into HIV/AIDS
These funds are to support research and educational work regarding Arthritis at the Royal London
Homoeopathic Hospital (now known as the Royal London Hospital for Integrated Medicine)
These funds were to support the Cancer Clinical Trials Unit (primarily GI)
These funds are for the UCH Macmillan Cancer Centre
These funds are to support research work into Cardiology
These funds are to provide equipment and patient information packs for the Colorectal Cancer
Unit
(7.)
(8.)
(9.)
(10.)
(11.)
(12.)
(13.)
(14.)
(15.)
(16.)
(17.)
These funds were to support the COX2 Sarcoid project
These funds are to support Dr Seddon's Sarcoma Fund
These funds are to support the Early Lung Cancer Detection & Treatment Programme
These funds were to support Learning Disability Services throughout the Trust
These funds were for Lifebox
These funds are to support the UCLH Lung & Heart Bioresource
These funds are to support Lungs for Living
These funds are to support the Stroke Services Department at UCLH
These funds are to support Mitochondrial Research
These funds were to support a multi-sensory room
These funds were used to support a Paediatric Oncology Research Nurse and research work into
Paediatric Oncology
(18.)
(19.)
(20.)
(21.)
These funds are to provide recreational facilities for the T11 Paediatric Ward
These funds are to support the Obstetrics work of Pranav Pandya and the Fetal Medicine Unit
These funds were for a Radiopharmacy Facility
These funds were for the complementary and alternative medicine library and information centre at
the Royal London Homoeopathic Hospital (now known as the Royal London Hospital for Integrated
Medicine)
(22.)
These funds were for research carried out at Royal London Homeopathic Hospital (now known
as the Royal London Hospital for Integrated Medicine)
(23.)
These funds were to support the Roald Dahl Marvellous Children's Charity Play Specialist

THE UNIVERSITY COLLEGE LONDON
HOSPITALS CHARITABLE FOUNDATION
Notes to the financial statements
For the year ended 31 March 2025 (continued)
12.
Restricted funds (continued)
Notes
(24.)
These funds are to support work around Mayer Rokitansky Kuster Hauser Syndrome - also known
as DSD (Differences of Sex Development)
(25.)
These funds are to support the Play Specialists at the Royal National Throat, Nose and Ear
Hospital (RNTNE) and the Nuffield Hearing and Speech Centre
(26.)
These funds are to support services at the Royal National Throat, Nose & Ear Hospital
(27.) These funds are for research into Sarcoid / Cryptogenic Fibrosing Alveolitis (CFA)
(28.)
These funds were to support the Severe Asthma Unit
(29.)
These In Memoriam donations for Stephen Green are used to predominantly support the maternity
ward at UCH (as well as other areas)
(30.) These funds are to support Stroke Unit throughout the Trust
(31.)
(32.)
(33.)
These funds were to support Therapy Services throughout the Trust
These funds were to support the Transplant Unit
These funds are to support the UCH Paediatric Epilepsy Unit
(34.) These funds are used to support the Young People's Unit
13.
Related parties
During the year UCL Hospitals Charitable Foundation continued its primary focus of supporting various projects across
the hospitals within the UCLH NHS Foundation Trust. During the year, the UCH NHS Foundation Trust recharged
salary costs to The University College London Hospitals Charitable Foundation of £86,774 (2024; £82,214). At the
year-end there was £7,231 due to the UCLH NHS Foundation Trust (2024: £16,761).
20

THE UNIVERSITY COLLEGE LONDON
HOSPITALS CHARITABLE FOUNDATION
Notes to the financial statements
For the year ended 31 March 2025 (continued)
14.
Prior Period Adjustment
In 2022/23, the Charity made a commitment to fund a Lung & Bioresource Clinical Fellow for a total of
£235,531.. No candidate was hired at the time and no liability was recorded in the 2022/23 financial year.
At the commencement of the 2024/25 financial year, the Clinical Fellow position was filled, and the charity
has commenced funding for the position. The nature of the original commitment has been reevaluated in
line with the treatment of the SORP, and it is deemed that the Charity's commitment in 2022/23 should lead
to a full recognition in that period as opposed to 2024/25. This has been reflected within the Lung & Heart
Bioresource restricted fund (See Note 12 (12)) which has an amended brought forward restricted fund
balance of £1,332 as at 01 April 2023 (following the prior period adjustment).
The following reported amounts have been adjusted in the primary statements:
2023
(reported)
2023
2023
adjustment (restated)
2024
2024
2024
(reported)
adjustment (restated)
394,659
(294,811)
235,531
(235,531)
630,190
(530,342)
Income Statement
Charitable activities
Net expenditure
Balance Sheet
Creditors < 1 year
Creditors > 1 year
Restricted funds
(71,049)
558,218
(71,049)
(235,531) (235,531)
(235,531)
322,687
(28,810)
550,546
(78,856)
(107,666)
(156,675)
(156,675)
(235,531)
315,015